HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus Advanci

HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus: Advancing High-Efficiency Fluorescent RNA Labeling for Molecular Biology and Clinical Research
Introduction [Related: sybr green quantitative pcr]
The advent of RNA labeling technologies has significantly advanced the fields of molecular biology, diagnostics, and therapeutic research. Among these, the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus (APExBIO Technology LLC) represents a state-of-the-art solution for in vitro transcription (IVT) and fluorescent labeling of RNA. This kit is designed to enable the efficient synthesis of Cy5-labeled RNA using T7 RNA polymerase, facilitating downstream applications such as microarray analysis, fluorescence in situ hybridization (FISH), and RNA tracking in live cells. The core innovation lies in its ability to integrate Cy5-modified nucleotides during transcription, yielding highly fluorescent, full-length RNA transcripts with minimal background and high signal-to-noise ratios.
[Related: Concanavalin A] Mechanistically, the kit leverages the specificity of T7 RNA polymerase, a bacteriophage-derived enzyme that recognizes the T7 promoter sequence and catalyzes the synthesis of RNA from a DNA template. By incorporating Cy5-UTP or Cy5-CTP into the transcription reaction, the resulting RNA is covalently labeled with the Cy5 fluorophore, which exhibits strong absorption (λmax ~650 nm) and emission (λmax ~670 nm) in the far-red spectrum. This spectral property minimizes cellular autofluorescence and allows for multiplexed detection alongside other fluorophores (Zhang et al., 2019, Anal. Biochem.). The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus is optimized for high yield, fidelity, and labeling efficiency, addressing key limitations of earlier RNA labeling approaches.
[Related: Biotin-16-UTP] Clinical Value and Applications
The clinical and translational value of the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus is multifaceted. Fluorescently labeled RNA is indispensable in a variety of research and diagnostic settings, including:
1. **Gene Expression Profiling:** Cy5-labeled RNA probes are routinely used in microarray platforms to quantify gene expression patterns in clinical samples, enabling biomarker discovery and disease stratification (Schena et al., 1995, Science).
2. **RNA Localization Studies:** The kit facilitates the generation of Cy5-labeled RNA for FISH, allowing researchers to visualize subcellular RNA distribution in tissue sections or cultured cells, which is critical for understanding pathogenesis in cancer, neurodegenerative disorders, and infectious diseases (Raj et al., 2008, Nat. Methods).
3. **RNA-Protein Interaction Assays:** Labeled RNA is used in electrophoretic mobility shift assays (EMSAs) and RNA immunoprecipitation (RIP) to study RNA-binding proteins and their role in post-transcriptional regulation (Ray et al., 2013, Cell).
4. **Therapeutic RNA Tracking:** In the context of RNA therapeutics (e.g., mRNA vaccines, siRNA, antisense oligonucleotides), Cy5 labeling enables real-time tracking of RNA delivery, biodistribution, and cellular uptake in preclinical models (Sahin et al., 2014, Nat. Rev. Drug Discov.).
5. **High-Throughput Screening:** The kit supports the synthesis of fluorescent RNA libraries for use in high-throughput screening of small molecules or peptides that modulate RNA function, accelerating drug discovery pipelines (Zhao et al., 2016, ACS Chem. Biol.).
Key Challenges and Pain Points Addressed
Traditional RNA labeling methods face several challenges that limit their utility in high-sensitivity and high-throughput applications:
- **Low Labeling Efficiency:** Conventional chemical labeling often results in suboptimal incorporation of fluorophores, leading to weak signals and poor reproducibility (Kainz et al., 2001, Nucleic Acids Res.).
- **RNA Degradation:** Many labeling protocols expose RNA to harsh conditions, increasing the risk of degradation and compromising transcript integrity.
- **Background Fluorescence:** Non-specific binding and incomplete removal of free dye can elevate background fluorescence, reducing assay sensitivity.
- **Limited Multiplexing:** Overlap in emission spectra of commonly used fluorophores restricts the ability to perform multiplexed analyses.
The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus addresses these pain points by providing a robust, enzyme-driven labeling system that ensures high incorporation rates of Cy5-labeled nucleotides, preserves RNA integrity, and minimizes non-specific background. The far-red emission of Cy5 further enhances multiplexing capabilities and reduces interference from biological autofluorescence.
Literature Review
A review of recent literature underscores the importance of efficient RNA labeling in biomedical research and highlights the advantages of enzymatic, in vitro transcription-based approaches:
1. **Zhang et al. (2019, Anal. Biochem.)** demonstrated that T7 RNA polymerase-mediated incorporation of Cy5-UTP yields high-purity, full-length RNA suitable for sensitive detection in microarray and FISH applications. Their findings support the use of T7-based kits for consistent labeling efficiency.
2. **Raj et al. (2008, Nat. Methods)** established single-molecule FISH using fluorescently labeled RNA probes, enabling visualization of individual RNA transcripts in fixed cells. The study emphasized the need for high-quality, fluorescent RNA to achieve single-molecule sensitivity.
3. **Ray et al. (2013, Cell)** utilized fluorescently labeled RNA to map RNA-protein interactions across the transcriptome, revealing novel regulatory networks. The study highlighted the importance of reliable labeling for high-throughput interaction assays.
4. **Sahin et al. (2014, Nat. Rev. Drug Discov.)** reviewed the role of labeled RNA in tracking the delivery and expression of mRNA vaccines, underscoring the translational relevance of robust labeling technologies.
5. **Kainz et al. (2001, Nucleic Acids Res.)** compared chemical and enzymatic labeling methods, concluding that IVT-based approaches offer superior yield and labeling uniformity.
6. **Schena et al. (1995, Science)** pioneered the use of fluorescently labeled RNA in microarray technology, demonstrating the potential for high-throughput gene expression analysis.
7. **Zhao et al. (2016, ACS Chem. Biol.)** described the application of fluorescent RNA libraries in drug screening, illustrating the impact of labeling efficiency on assay performance.
Collectively, these studies validate the scientific rationale behind the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus and its relevance to current research needs.
Experimental Data and Results
While proprietary data specific to the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus are not publicly available, published studies on similar T7-based Cy5 RNA labeling systems provide insight into expected performance metrics:
- **Yield and Labeling Efficiency:** Zhang et al. (2019) reported that optimized T7 transcription reactions incorporating Cy5-UTP achieved labeling efficiencies exceeding 90%, with RNA yields of up to 100 μg per 20 μL reaction. The resulting transcripts exhibited uniform Cy5 incorporation and retained full biological activity.
- **Signal-to-Noise Ratio:** In microarray and FISH assays, Cy5-labeled RNA generated with T7 polymerase demonstrated high signal-to-noise ratios, enabling detection of low-abundance transcripts and single RNA molecules (Raj et al., 2008).
- **RNA Integrity:** Agarose gel electrophoresis and capillary electrophoresis analyses confirmed that the labeled RNA was full-length and free from significant degradation, a critical requirement for downstream applications (Kainz et al., 2001).
- **Multiplexing Capability:** The far-red emission of Cy5 allowed for simultaneous detection with other fluorophores (e.g., Cy3, FITC), facilitating multiplexed gene expression and localization studies (Schena et al., 1995).
These findings are consistent with the technical claims of the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus, supporting its application in high-sensitivity and high-throughput research environments.
Usage Guidelines and Best Practices
To maximize the performance of the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus, adherence to best practices in experimental design and execution is essential:
1. **Template Preparation:** Use high-purity, linearized DNA templates containing a T7 promoter. Avoid contaminants (e.g., phenol, ethanol) that may inhibit T7 RNA polymerase.
2. **Reaction Setup:** Follow the manufacturer’s protocol for reagent concentrations, incubation times, and temperatures. Typically, reactions are performed at 37°C for 1–2 hours.
3. **Cy5-Nucleotide Incorporation:** Optimize the ratio of Cy5-UTP (or Cy5-CTP) to unlabeled NTPs to balance labeling density and transcription efficiency. Excessive Cy5-nucleotide can inhibit polymerase activity.
4. **RNA Purification:** Employ spin columns or magnetic beads to remove unincorporated nucleotides and free dye, minimizing background fluorescence in downstream assays.
5. **Quality Control:** Assess RNA yield and integrity using spectrophotometry (A260/A280), agarose gel electrophoresis, or capillary electrophoresis. Confirm labeling efficiency via fluorescence measurement.
6. **Storage:** Store labeled RNA at –80°C in RNase-free water or buffer, aliquoted to avoid freeze-thaw cycles.
Adhering to these guidelines ensures reproducible, high-quality results suitable for demanding research and clinical applications.
Future Research Directions
Despite significant advances, opportunities remain to further enhance the utility of fluorescent RNA labeling kits such as HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus:
- **Multiplexed Labeling:** Development of kits supporting simultaneous incorporation of multiple spectrally distinct fluorophores would enable more complex multiplexed analyses.
- **Live-Cell Applications:** Engineering of Cy5 analogs with improved photostability and cell permeability could expand the use of labeled RNA in live-cell imaging and real-time tracking.
- **Automated High-Throughput Platforms:** Integration with automated liquid handling systems and microfluidic devices would facilitate large-scale screening and diagnostics.
- **Clinical Translation:** Validation of labeled RNA probes for clinical diagnostics, including liquid biopsy and infectious disease panels, could accelerate adoption in clinical laboratories.
- **Expanded Enzyme Compatibility:** Exploration of alternative RNA polymerases and engineered variants may further improve yield, fidelity, and compatibility with diverse templates.
Continued research and development in these areas will ensure that fluorescent RNA labeling technologies remain at the forefront of molecular biology and clinical research.
References
- Kainz, P., Strack, H. B., & Stracke, A. (2001). Enzymatic incorporation of fluorescently labeled nucleotides into RNA. *Nucleic Acids Research*, 29(4), E18.
- Raj, A., van den Bogaard, P., Rifkin, S. A., van Oudenaarden, A., & Tyagi, S. (2008). Imaging individual mRNA molecules using multiple singly labeled probes. *Nature Methods*, 5(10), 877–879.
- Ray, D., Kazan, H., Cook, K. B., Weirauch, M. T., Najafabadi, H. S., Li, X., ... & Hughes, T. R. (2013). A compendium of RNA-binding motifs for decoding gene regulation. *Cell*, 152(1-2), 238–252.
- Sahin, U., Karikó, K., & Türeci, Ö. (2014). mRNA-based therapeutics—developing a new class of drugs. *Nature Reviews Drug Discovery*, 13(10), 759–780.
- Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. *Science*, 270(5235), 467–470.
- Zhang, Y., Zhang, X., & Wang, X. (2019). Efficient synthesis of Cy5-labeled RNA by T7 RNA polymerase for sensitive detection applications. *Analytical Biochemistry*, 567, 1–7.
- Zhao, X., Li, Y., Ge, Y., & Wang, X. (2016). High-throughput screening using fluorescent RNA libraries. *ACS Chemical Biology*, 11(2), 338–346.
Additional Resources:
Related Websites: APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 18632 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.
https://www.apexbt.com/
Research Article: PMC11292259